Morepen Laboratories Delivers Record Q2, H1 FY27 Performance, With CDMO And Exports Driving Strong Growth
Mumbai: Morepen Laboratories on Friday announced its financial results for the quarter and half year ended September 30, 2026, reporting its second consecutive quarter of record revenue and earnings. Q2 Financial Performance Sales revenue for the second quarter of FY27 increased by 81 per cent year-on-year to ₹755 crore. Profit after tax (PAT) rose 117 per cent to ₹89 crore, while the EBITDA…
We haven't written up this one. Free Press Journal has the full story — the link below goes straight to it.
